110 related articles for article (PubMed ID: 6230055)
1. [Phase II study of FF-705 by Clinical Cooperative Study Group].
Gan To Kagaku Ryoho; 1984 Jan; 11(1):150-6. PubMed ID: 6230055
[TBL] [Abstract][Full Text] [Related]
2. [Phase I study of a new floxuridine derivative, 2'-deoxy-3', 5'-di-O-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine (FF-705)].
Gan To Kagaku Ryoho; 1984 Jan; 11(1):143-9. PubMed ID: 6230054
[TBL] [Abstract][Full Text] [Related]
3. [Clinical phase II study of TK-117 by Cooperative Study Group. Effects on gastric cancer].
Suzuki H
Gan To Kagaku Ryoho; 1985 May; 12(5):1119-24. PubMed ID: 3158282
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
[TBL] [Abstract][Full Text] [Related]
5. [Cooperative phase II study of spansule tegafur (SF-SP)].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
[TBL] [Abstract][Full Text] [Related]
6. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
Futatsuki K; Komita T; Kamano T; Watanabe H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478
[TBL] [Abstract][Full Text] [Related]
7. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
Nakatsu T; Takahashi H; Furue H
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
[TBL] [Abstract][Full Text] [Related]
9. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
10. [Phase I clinical study of TT-62. Research group of TT-62].
Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
[TBL] [Abstract][Full Text] [Related]
12. [Phase I study of SM-5887, a new anthracycline derivative].
Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1988 May; 15(5):1771-6. PubMed ID: 3369871
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
[TBL] [Abstract][Full Text] [Related]
14. [Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers].
Ibayashi J
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1414-9. PubMed ID: 6430244
[TBL] [Abstract][Full Text] [Related]
15. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
Taguchi T; Terasawa T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
[TBL] [Abstract][Full Text] [Related]
16. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
Chang AY; Boros L; Asbury R; Hui L; Rubins J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
[TBL] [Abstract][Full Text] [Related]
18. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
Rinehart J; Adjei AA; Lorusso PM; Waterhouse D; Hecht JR; Natale RB; Hamid O; Varterasian M; Asbury P; Kaldjian EP; Gulyas S; Mitchell DY; Herrera R; Sebolt-Leopold JS; Meyer MB
J Clin Oncol; 2004 Nov; 22(22):4456-62. PubMed ID: 15483017
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
[TBL] [Abstract][Full Text] [Related]
20. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
